Conference report from ObesityWeek covering new clinical data presentations on semaglutide, tirzepatide, and retatrutide. Summarizes emerging findings on efficacy, safety, mechanisms, and clinical questions raised by these agents, including debates about comparative effectiveness, long-term use, and patient selection. Captures the state of the field as retatrutide entered advanced development.
Ruder, Kate